enVVeno Medical Corporation
NVNO
$10.53
$0.232.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.30% | -19.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.96% | -15.50% | |||
| Operating Income | 15.96% | 15.50% | |||
| Income Before Tax | 17.69% | 32.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.69% | 32.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.69% | 32.19% | |||
| EBIT | 15.96% | 15.50% | |||
| EBITDA | 16.06% | 15.54% | |||
| EPS Basic | 23.21% | 31.53% | |||
| Normalized Basic EPS | 20.77% | 14.85% | |||
| EPS Diluted | 23.21% | 31.53% | |||
| Normalized Diluted EPS | 20.77% | 14.85% | |||
| Average Basic Shares Outstanding | 7.17% | -0.96% | |||
| Average Diluted Shares Outstanding | 7.17% | -0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||